Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6

Article

Abstract: In bioequivalence studies, intra-individual variability (CV w) is critical in determining sample siz

Palabras claves:

bioequivalence, Cost, CYP2D6, Genotypes, intra-individual, variability

Autores:

Abad-Santos F., Adrián LLerena, Carcas-Sansuan A., Dorado P., Estévez-Carrizo F.E., González-Vacarezza N., Penãs-Lledó E.M.

Fuentes:

scopus